Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases.

Membrane-type matrix metalloproteinases (MT-MMP) constitute a subfamily of six distinct membrane-associated MMPs. Although the contribution of MT1-MMP during different steps of cancer progression has been well documented, the significance of other MT-MMPs is rather unknown. We have investigated the involvement of MT4-MMP, a glycosylphosphatidylinositol-anchored protease, in breast cancer progression. Interestingly, immunohistochemical analysis shows that MT4-MMP production at protein level is strongly increased in epithelial cancer cells of human breast carcinomas compared with normal epithelial cells. Positive staining for MT4-MMP is also detected in lymph node metastases. In contrast, quantitative reverse transcription-PCR analysis reveals similar MT4-MMP mRNA levels in human breast adenocarcinomas and normal breast tissues. Stable transfection of MT4-MMP cDNA in human breast adenocarcinoma MDA-MB-231 cells does not affect in vitro cell proliferation or invasion but strongly promotes primary tumor growth and associated metastases in RAG-1 immunodeficient mice. We provide for the first time evidence that MT4-MMP overproduction accelerates in vivo tumor growth, induces enlargement of i.t. blood vessels, and is associated with increased lung metastases. These results identify MT4-MMP as a new putative target to design anticancer strategies.

[1]  V. Yong,et al.  Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells. , 2003, Molecular cancer research : MCR.

[2]  Jean-Michel Foidart,et al.  Improved quantification of angiogenesis in the rat aortic ring assay , 2004, Angiogenesis.

[3]  G. Velasco,et al.  Catalytic activities of membrane‐type 6 matrix metalloproteinase (MMP25) , 2001, FEBS letters.

[4]  J. Foidart,et al.  Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases* , 2004, Journal of Biological Chemistry.

[5]  D. Edwards,et al.  Metalloproteinases and their inhibitors in tumor angiogenesis , 2005, International journal of cancer.

[6]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[7]  A. Ferrando,et al.  Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. , 2000, Cancer research.

[8]  R. Klebe,et al.  Overview of expression of matrix metalloproteinases (MMP-17, MMP-18, and MMP-20) in cultured human cells. , 1999, Matrix biology : journal of the International Society for Matrix Biology.

[9]  Motoharu Seiki,et al.  A matrix metalloproteinase expressed on the surface of invasive tumour cells , 1994, Nature.

[10]  References , 1971 .

[11]  Hiroshi Sato,et al.  Human membrane type‐4 matrix metalloproteinase (MT4‐MMP) is encoded by a novel major transcript: isolation of complementary DNA clones for human and mouse mt4‐mmp transcripts , 1999, FEBS letters.

[12]  A. Strongin,et al.  The transmembrane domain is essential for the microtubular trafficking of membrane type-1 matrix metalloproteinase (MT1-MMP) , 2005, Journal of Cell Science.

[13]  J. Sandy,et al.  ADAMTS4 (Aggrecanase-1) Activation on the Cell Surface Involves C-terminal Cleavage by Glycosylphosphatidyl Inositol-anchored Membrane Type 4-Matrix Metalloproteinase and Binding of the Activated Proteinase to Chondroitin Sulfate and Heparan Sulfate on Syndecan-1* , 2004, Journal of Biological Chemistry.

[14]  P. Carmeliet,et al.  Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent manner. , 2005, Neoplasia.

[15]  C. Ferland,et al.  Expression of membrane type-4 matrix metalloproteinase (metalloproteinase-17) by human eosinophils. , 2003, The international journal of biochemistry & cell biology.

[16]  C. López-Otín,et al.  Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. , 2004, The International journal of developmental biology.

[17]  K. Paigen,et al.  A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.

[18]  L. Devy,et al.  MT1‐MMP expression promotes tumor growth and angiogenesis through an up‐regulation of vascular endothelial growth factor expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  X. Puente,et al.  Membrane Type 4 Matrix Metalloproteinase (MMP17) Has Tumor Necrosis Factor-α Convertase Activity but Does Not Activate Pro-MMP2* , 2000, The Journal of Biological Chemistry.

[20]  A. Strongin,et al.  Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. , 2002, Cancer research.

[21]  C. Gilles,et al.  Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[22]  P. Patwari,et al.  Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage. , 2005, Osteoarthritis and cartilage.

[23]  X. Puente,et al.  Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. , 1996, Cancer research.

[24]  Y. Itoh,et al.  Membrane Type 4 Matrix Metalloproteinase (MT4-MMP, MMP-17) Is a Glycosylphosphatidylinositol-anchored Proteinase* , 1999, The Journal of Biological Chemistry.

[25]  C. Fombrun,et al.  Matrix , 1979, Encyclopedic Dictionary of Archaeology.

[26]  Y. Okada,et al.  Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. , 1996, Cancer research.

[27]  Steven Shapiro,et al.  Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP , 2004, The Journal of cell biology.

[28]  A. Strongin,et al.  Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.

[29]  J. Foidart,et al.  Membrane Type 1 Matrix Metalloproteinase-associated Degradation of Tissue Inhibitor of Metalloproteinase 2 in Human Tumor Cell Lines* , 2000, The Journal of Biological Chemistry.

[30]  B. Nielsen,et al.  Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. , 2005, Carcinogenesis.

[31]  Yibin Kang.  Functional genomic analysis of cancer metastasis: biologic insights and clinical implications , 2005, Expert review of molecular diagnostics.

[32]  C. López-Otín,et al.  Membrane type-matrix metalloproteinases (MT-MMP). , 2003, Current topics in developmental biology.

[33]  M. Seiki,et al.  Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis , 2003, Cancer and Metastasis Reviews.

[34]  H. Birkedal‐Hansen,et al.  Expression pattern of four membrane‐type matrix metalloproteinases in the normal and diseased mouse mammary gland , 2005, Journal of cellular physiology.

[35]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[36]  R. Ball,et al.  Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues , 2005, British Journal of Cancer.

[37]  J. Foidart,et al.  Membrane associated proteases and their inhibitors in tumour angiogenesis , 2004, Journal of Clinical Pathology.

[38]  J. Foidart,et al.  Restricted expression of membrane type 1‐matrix metalloproteinase by myofibroblasts adjacent to human breast cancer cells , 2003, International journal of cancer.

[39]  M. Waltham,et al.  Pro-Matrix Metalloproteinase-2 Transfection Increases Orthotopic Primary Growth and Experimental Metastasis of MDA-MB-231 Human Breast Cancer Cells in Nude Mice , 2004, Cancer Research.

[40]  A. Noël,et al.  Membrane type-matrix metalloproteinases and tumor progression. , 2005, Biochimie.

[41]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[42]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[43]  C. Overall,et al.  Cellular Activation of MMP-2 (Gelatinase A) by MT2-MMP Occurs via a TIMP-2-independent Pathway* , 2001, The Journal of Biological Chemistry.

[44]  L. Coussens,et al.  The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. , 2005, Cancer research.

[45]  J. Foidart,et al.  Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. , 1993, British Journal of Cancer.